SCHEMBL6978477

SCHEMBL6978477

Cc1ccc(C2(C(=O)O)OCC(c3ccccc3)(c3ccccc3)CO2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.39
CYP2C19 P33261 2/20 0.38
OPRM1 P35372 3/20 0.38
OPRL1 P41146 2/20 0.38
OPRK1 P41145 1/20 0.38
CES2 O00748 1/20 0.37
CES1 P23141 1/20 0.37
L3MBTL1 Q9Y468 2/20 0.36
CYP1A2 P05177 1/20 0.36
AKR1C1 Q04828 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
CHRNB2 P17787 2/20 0.35
SLC6A2 P23975 2/20 0.35
CHRNB4 P30926 2/20 0.35
CHRNA3 P32297 2/20 0.35
CHRNA4 P43681 2/20 0.35
SLC6A3 Q01959 2/20 0.35
MEN1 O00255 2/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6981777 0.90 AKR1C1 (0.41) LMNAOPRM1OPRL1L3MBTL1AKR1C1
SCHEMBL6967893 0.84 CNR1 (0.40) CES2CES1L3MBTL1AKR1C1KMT2A
SCHEMBL6982594 0.84 HSD11B1 (0.39) CYP2C19AKR1C1SMN1; SMN2CHRNB2SLC6A2
SCHEMBL6971207 0.84 OPRM1 (0.44) OPRM1OPRL1CES2CES1L3MBTL1
SCHEMBL6979724 0.83 OPRM1 (0.45) LMNAOPRM1OPRK1L3MBTL1SMN1; SMN2
SCHEMBL6981080 0.81 THRB (0.44) LMNAOPRM1OPRL1OPRK1CES2
SCHEMBL377756 0.79 MAPK1 (0.40) CHRNB2SLC6A2CHRNB4CHRNA3CHRNA4
SCHEMBL6973280 0.78 SLC6A2 (0.37) CYP2C19SMN1; SMN2CHRNB2SLC6A2CHRNB4
SCHEMBL7823214 0.77 KIF11 (0.36) LMNA
SCHEMBL6984599 0.76 RXRA (0.53) LMNACYP2C19CYP1A2SMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1098893-B1 CYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF DYSLIPIDEMIA, ATHEROSCLEROSIS AND DIABETES, PHARMACEUTICAL COMPOSITIONS AND PREPARATION PROCESS MERCK PATENT GMBH (DE) 2003-03-26 EP disclosed